栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/24 | 1,632 | 1,654 | 1,621 | 1,652 | +28 | +1.7% | 115,100 |
2023/01/23 | 1,619 | 1,624 | 1,603 | 1,624 | +25 | +1.6% | 102,300 |
2023/01/20 | 1,609 | 1,609 | 1,592 | 1,599 | -7 | -0.4% | 127,800 |
2023/01/19 | 1,613 | 1,618 | 1,595 | 1,606 | -14 | -0.9% | 164,700 |
2023/01/18 | 1,585 | 1,620 | 1,585 | 1,620 | +43 | +2.7% | 109,500 |
2023/01/17 | 1,590 | 1,594 | 1,566 | 1,577 | -12 | -0.8% | 170,000 |
2023/01/16 | 1,598 | 1,603 | 1,581 | 1,589 | -27 | -1.7% | 145,100 |
2023/01/13 | 1,636 | 1,643 | 1,610 | 1,616 | -26 | -1.6% | 113,300 |
2023/01/12 | 1,643 | 1,657 | 1,626 | 1,642 | -1 | -0.1% | 125,300 |
2023/01/11 | 1,623 | 1,657 | 1,622 | 1,643 | +23 | +1.4% | 155,000 |
2023/01/10 | 1,638 | 1,646 | 1,618 | 1,620 | -22 | -1.3% | 91,800 |
2023/01/06 | 1,635 | 1,644 | 1,625 | 1,642 | +11 | +0.7% | 79,000 |
2023/01/05 | 1,638 | 1,640 | 1,613 | 1,631 | -25 | -1.5% | 113,100 |
2023/01/04 | 1,704 | 1,704 | 1,654 | 1,656 | -53 | -3.1% | 117,300 |
2022/12/30 | 1,697 | 1,721 | 1,696 | 1,709 | -6 | -0.3% | 208,000 |
2022/12/29 | 1,715 | 1,720 | 1,699 | 1,715 | +5 | +0.3% | 191,100 |
2022/12/28 | 1,715 | 1,715 | 1,696 | 1,710 | -24 | -1.4% | 167,200 |
2022/12/27 | 1,718 | 1,743 | 1,713 | 1,734 | +31 | +1.8% | 183,800 |
2022/12/26 | 1,710 | 1,716 | 1,691 | 1,703 | ±0 | ±0% | 144,500 |
2022/12/23 | 1,720 | 1,720 | 1,696 | 1,703 | -32 | -1.8% | 134,300 |
2022/12/22 | 1,737 | 1,745 | 1,724 | 1,735 | -18 | -1% | 127,100 |
2022/12/21 | 1,771 | 1,783 | 1,730 | 1,753 | -32 | -1.8% | 172,700 |
2022/12/20 | 1,853 | 1,858 | 1,771 | 1,785 | -60 | -3.3% | 321,200 |
2022/12/19 | 1,819 | 1,846 | 1,819 | 1,845 | +7 | +0.4% | 123,000 |
2022/12/16 | 1,838 | 1,855 | 1,831 | 1,838 | -14 | -0.8% | 133,500 |
2022/12/15 | 1,863 | 1,864 | 1,851 | 1,852 | -12 | -0.6% | 28,300 |
2022/12/14 | 1,852 | 1,870 | 1,850 | 1,864 | +24 | +1.3% | 105,800 |
2022/12/13 | 1,850 | 1,862 | 1,837 | 1,840 | -14 | -0.8% | 67,000 |
2022/12/12 | 1,853 | 1,860 | 1,839 | 1,854 | +2 | +0.1% | 69,700 |
2022/12/09 | 1,837 | 1,854 | 1,824 | 1,852 | +29 | +1.6% | 76,500 |
2022/12/08 | 1,819 | 1,833 | 1,808 | 1,823 | +6 | +0.3% | 84,700 |
2022/12/07 | 1,787 | 1,826 | 1,782 | 1,817 | +33 | +1.8% | 78,200 |
2022/12/06 | 1,790 | 1,796 | 1,775 | 1,784 | -12 | -0.7% | 75,500 |
2022/12/05 | 1,821 | 1,821 | 1,788 | 1,796 | -30 | -1.6% | 85,200 |
2022/12/02 | 1,865 | 1,866 | 1,825 | 1,826 | -51 | -2.7% | 104,800 |
2022/12/01 | 1,906 | 1,906 | 1,866 | 1,877 | -26 | -1.4% | 72,200 |
2022/11/30 | 1,917 | 1,917 | 1,889 | 1,903 | -30 | -1.6% | 119,700 |
2022/11/29 | 1,941 | 1,951 | 1,922 | 1,933 | -20 | -1% | 106,300 |
2022/11/28 | 1,979 | 1,979 | 1,943 | 1,953 | -38 | -1.9% | 129,600 |
2022/11/25 | 1,986 | 1,998 | 1,981 | 1,991 | +15 | +0.8% | 87,500 |
2022/11/24 | 1,960 | 1,987 | 1,960 | 1,976 | +16 | +0.8% | 91,000 |
2022/11/22 | 1,950 | 1,979 | 1,946 | 1,960 | +16 | +0.8% | 181,600 |
2022/11/21 | 1,931 | 1,950 | 1,931 | 1,944 | +13 | +0.7% | 61,200 |
2022/11/18 | 1,940 | 1,948 | 1,923 | 1,931 | -5 | -0.3% | 103,600 |
2022/11/17 | 1,920 | 1,937 | 1,909 | 1,936 | +16 | +0.8% | 107,500 |
2022/11/16 | 1,913 | 1,928 | 1,907 | 1,920 | -2 | -0.1% | 98,500 |
2022/11/15 | 1,910 | 1,931 | 1,907 | 1,922 | +14 | +0.7% | 87,100 |
2022/11/14 | 1,892 | 1,915 | 1,879 | 1,908 | +13 | +0.7% | 71,700 |
2022/11/11 | 1,902 | 1,906 | 1,886 | 1,895 | +36 | +1.9% | 121,400 |
2022/11/10 | 1,864 | 1,877 | 1,853 | 1,859 | -23 | -1.2% | 93,200 |
451~
500
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 210,500円 | +0.4% | -8.4% | 2.52% | 27.82倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 72,300円 | -3.7% | -36.7% | 2.77% | 23.81倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 95,200円 | - | - | 0.00% | - | 47.93倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
あすかHD | 204,400円 | +0.3% | +2.7% | 2.45% | 11.60倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム